Published in Postgrad Med J on February 01, 2006
Taxol, a microtubule stabilizer, prevents ischemic ventricular arrhythmias in rats. J Cell Mol Med (2010) 0.83
Cell and gene therapy for arrhythmias: Repair of cardiac conduction damage. J Geriatr Cardiol (2011) 0.79
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med (1998) 23.22
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med (2004) 18.38
A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med (2002) 16.31
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med (1996) 15.04
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med (1991) 13.91
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol (1992) 12.18
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med (1997) 10.02
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med (2002) 8.37
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
Risk stratification in the long-QT syndrome. N Engl J Med (2003) 7.25
Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation (2005) 6.68
Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation (2000) 6.56
Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation (2000) 5.09
Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med (2004) 4.99
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation (2000) 4.12
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99
Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation (2003) 3.99
Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation (2000) 3.98
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol (2003) 3.38
Natural history of Brugada syndrome: insights for risk stratification and management. Circulation (2002) 3.10
Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J (2001) 2.93
Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation (2001) 2.85
"Brugada" syndrome: clinical data and suggested pathophysiological mechanism. Circulation (1999) 2.83
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol (2003) 2.73
Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation (1993) 2.71
Long QT Syndrome. JAMA (2003) 2.70
Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation (1998) 2.67
Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation (1998) 2.53
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation (1990) 2.51
An 8 1/2-year clinical experience with surgery for atrial fibrillation. Ann Surg (1996) 2.43
The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J (1999) 2.28
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol (2002) 2.14
The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol (2000) 2.06
Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J (2003) 1.99
Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation (2002) 1.91
Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease. J Am Coll Cardiol (2003) 1.86
Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol (2000) 1.68
A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med (1993) 1.67
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol (1992) 1.55
Electrophysiological effects of catheter ablation of inferior vena cava-tricuspid annulus isthmus in common atrial flutter. Circulation (1996) 1.54
Radiofrequency ablation for post infarction ventricular tachycardia. Report of a single centre experience of 112 cases. Eur Heart J (2002) 1.53
Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation (2001) 1.51
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J (2001) 1.46
Feasibility of a noncontact catheter for endocardial mapping of human ventricular tachycardia. Circulation (1999) 1.38
Differential pacing for distinguishing block from persistent conduction through an ablation line. Circulation (2000) 1.36
Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation (1998) 1.30
European Resuscitation Council Guidelines 2000 for Adult Advanced Life Support. A statement from the Advanced Life Support Working Group(1) and approved by the Executive Committee of the European Resuscitation Council. Resuscitation (2001) 1.29
Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol (1999) 1.25
Local electrogram-based criteria of cavotricuspid isthmus block. J Cardiovasc Electrophysiol (1999) 1.21
Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. J Am Coll Cardiol (2003) 1.18
Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation (1999) 1.13
Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation. Circulation (1993) 1.07
Epidemiology of sudden coronary death: an overview. Prog Cardiovasc Dis (1994) 1.03
Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients. Heart (2005) 1.02
Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation. Circulation (1999) 1.02
Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol (1995) 1.00
Catheter ablation of supraventricular arrhythmias: state of the art. Pacing Clin Electrophysiol (2004) 0.96
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol (1993) 0.95
Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation (1997) 0.94
Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. Am J Cardiol (1993) 0.91
Role of oral anticoagulation in management of atrial fibrillation. Heart (2004) 0.87
Electrophysiologically guided ablation of the pulmonary veins for the curative treatment of atrial fibrillation. Ann Med (2000) 0.86
Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF). Eur Heart J (2001) 0.81
Idiopathic left ventricular tachycardia. Cure by radiofrequency ablation. Circulation (1993) 0.78
Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest. J Am Coll Cardiol (1997) 0.76
Current perspectives on curative catheter ablation of atrial fibrillation. Heart (2002) 0.76
Treatment of catecholamine-sensitive right ventricular tachycardia by endocardial catheter ablation. J Am Coll Cardiol (1990) 0.76
Current standards in reported drug trials. Can Med Assoc J (1968) 1.70
Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation; a manifestation of atrial electrical remodelling in humans? Eur Heart J (2001) 1.41
Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans. Circulation (2000) 0.83
Relationship among prognostic laboratory indices in breast cancers. J Natl Cancer Inst (1992) 0.75
The 1978 Division 27 Award for Distinguished Contributions to Community Psychology and Community Mental Health: James G. Kelly. Am J Community Psychol (1979) 0.75